Ultrapreservation in Robotic Assisted Radical Prostatectomy Provides Early Continence Recovery
Journal of the Society of Laparoscopic and Robotic Surgeons, cilt.27, sa.1, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 27 Sayı: 1
- Basım Tarihi: 2023
- Doi Numarası: 10.4293/jsls.2022.00077
- Dergi Adı: Journal of the Society of Laparoscopic and Robotic Surgeons
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE
- Anahtar Kelimeler: Erectile dysfunction, Prostatectomy, Robotic-assisted surgery, Urinary incontinence
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background and Objectives: We aimed to evaluate oncological and functional results of the ultrapreservation anterior-sparing technique in patients with localized prostate cancer. Methods: In this single-center study, patients with low to intermediate risk prostate cancer, who were treated with the ultrapreservation anterior-sparing technique, were included retrospectively. The oncological and functional outcomes were recorded. After the functional and pathological evaluation in the first month, patients’ prostate-specific antigen levels were followed, as well as continence and potency status bimonthly for one year. Continence is defined as no leakage and zero pads for se-curity. Patients’ potency was evaluated using the Sexual Health Inventory for Men, with ≥ 17 considered potent. Results: A total of 118 patients were included in the study. The pathological stage was pT2 in 78% (n = 92) of patients, with pT3 in 22% (n = 26). Surgical margin posi-tivity occurred in 13.5% (n = 16) of patients. No complications were observed intraoperatively. Continence rates were 25.4% after catheter removal, rising to 88.9% in the first month, 91.5% in the third, 93.2% in the fifth, and 95.7% a year later. Thirty-five (40%) of 86 potent patients were potent in the first postoperative month, 48 patients (55.8%) were potent in the third month, and 58 patients (67.4%) were potent in the twelfth. The total complication rate was 8.4%, with no major complications observed. Conclusion: The ultrapreservation anterior-sparing technique for patients with prostate cancer shows safe, ac-ceptable functional and oncological results in short-term follow-up. However, long-term comparative studies with a larger number of patients are needed.